4728 Stock Overview
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Sunmax Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$275.50 |
| 52 Week High | NT$350.00 |
| 52 Week Low | NT$191.50 |
| Beta | 0.28 |
| 11 Month Change | 2.80% |
| 3 Month Change | -5.97% |
| 1 Year Change | 34.06% |
| 33 Year Change | 242.24% |
| 5 Year Change | 214.50% |
| Change since IPO | 579.91% |
Recent News & Updates
Recent updates
Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%
Feb 28
Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?
Feb 02Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?
Dec 20Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?
Nov 24
Shareholder Returns
| 4728 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -0.5% | -3.1% | -0.8% |
| 1Y | 34.1% | 2.0% | 29.0% |
Return vs Industry: 4728 exceeded the TW Biotechs industry which returned 0.1% over the past year.
Return vs Market: 4728 exceeded the TW Market which returned 29.2% over the past year.
Price Volatility
| 4728 volatility | |
|---|---|
| 4728 Average Weekly Movement | 3.4% |
| Biotechs Industry Average Movement | 4.5% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4728 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4728's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Ming Yi Lin | www.sunmaxbiotech.com |
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax FACIALGAIN collagen implant with lidocaine, Sunmax collagen implant I-Plus, Sumax collagen implant I, Sunmax FACIALGAIN collagen implant 1-Plus with lidocaine for the correction of facial defects, such as the fill up of wrinkles; and Porcogen, a sterile purified collagen solution for medical device, tissue engineering, and research purposes. It also provides Sunmax collagen dental bone graft, Sunmax collagen dental membrane, and Sunmax dental bone graft granules, which are used in the augmentation or reconstructive treatment of the alveolar ridge.
Sunmax Biotechnology Co., Ltd. Fundamentals Summary
| 4728 fundamental statistics | |
|---|---|
| Market cap | NT$15.00b |
| Earnings (TTM) | NT$698.95m |
| Revenue (TTM) | NT$1.74b |
21.5x
P/E Ratio8.6x
P/S RatioIs 4728 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4728 income statement (TTM) | |
|---|---|
| Revenue | NT$1.74b |
| Cost of Revenue | NT$314.37m |
| Gross Profit | NT$1.43b |
| Other Expenses | NT$730.04m |
| Earnings | NT$698.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.83 |
| Gross Margin | 81.97% |
| Net Profit Margin | 40.09% |
| Debt/Equity Ratio | 0% |
How did 4728 perform over the long term?
See historical performance and comparison